Contact Molecules for Homologous Proteins

[Full Bars]
[SiteTable]


Summary Bars[0.0 %]


[Back to Search Page]
[Back to HOMCOS]


[help] 		seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100]
[show] [download] [help]
PID QueryLength Homolgous Sequence in PDB UniProt Query TITLE
1704183 1255 500 P59594(SPIKE_SARS) RecName: Full=Spike glycoprotein ; Short=S glycoprotein ;AltName: Full=E2 ;AltName: Full=Peplomer protein ;Contains: RecName: Full=Spike protein S1 ;Contains: RecName: Full=Spike protein S2 ;Contains: RecName: Full=Spike protein S2' ;Flags: Precursor;
QUERYSEQ 
MFIFLLFLTLTSGSDLDRCTTFDDVQAPNYTQHTSSMRGVYYPDEIFRSDTLYLTQDLFLPFYSNVTGFHTINHTFGNPVIPFKDGIYFAATEKSNVVRGWVFGSTMNNKSQSVIIINNSTNVVIRACNFELCDNPFFAVSKPMGTQTHT
MIFDNAFNCTFEYISDAFSLDVSEKSGNFKHLREFVFKNKDGFLYVYKGYQPIDVVRDLPSGFNTLKPIFKLPLGINITNFRAILTAFSPAQDIWGTSAAAYFVGYLKPTTFMLKYDENGTITDAVDCSQNPLAELKCSVKSFEIDKGIY
QTSNFRVVPSGDVVRFPNITNLCPFGEVFNATKFPSVYAWERKKISNCVADYSVLYNSTFFSTFKCYGVSATKLNDLCFSNVYADSFVVKGDDVRQIAPGQTGVIADYNYKLPDDFMGCVLAWNTRNIDATSTGNYNYKYRYLRHGKLRP
FERDISNVPFSPDGKPCTPPALNCYWPLNDYGFYTTTGIGYQPYRVVVLSFELLNAPATVCGPKLSTDLIKNQCVNFNFNGLTGTGVLTPSSKRFQPFQQFGRDVSDFTDSVRDPKTSEILDISPCSFGGVSVITPGTNASSEVAVLYQD
VNCTDVSTAIHADQLTPAWRIYSTGNNVFQTQAGCLIGAEHVDTSYECDIPIGAGICASYHTVSLLRSTSQKSIVAYTMSLGADSSIAYSNNTIAIPTNFSISITTEVMPVSMAKTSVDCNMYICGDSTECANLLLQYGSFCTQLNRALS
GIAAEQDRNTREVFAQVKQMYKTPTLKYFGGFNFSQILPDPLKPTKRSFIEDLLFNKVTLADAGFMKQYGECLGDINARDLICAQKFNGLTVLPPLLTDDMIAAYTAALVSGTATAGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYE
NQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQAAPHGVVFLHVTYV
PSQERNFTTAPAICHEGKAYFPREGVFVFNGTSWFITQRNFFSPQIITTDNTFVSGNCDVVIGIINNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYVWL
GFIAGLIAIVMVTILLCCMTSCCSCLKGACSCGSCCKFDEDDSEPVLKGVKLHYT
[BLAST file for PDB] (plain) (bar) (multiple alignment) [BLAST for UniProt: (plain) (bar) (multiple alignment) (PSSM file) ]

UniProt Feature Tables [P59594(SPIKE_SARS)]

1255
region name description
1-13 SIGNAL
14-1255 CHAIN /note="Spike glycoprotein" /id="PRO_0000037208"
14-667 CHAIN /note="Spike protein S1" /id="PRO_0000037209"
668-1255 CHAIN /note="Spike protein S2" /id="PRO_0000037210"
798-1255 CHAIN /note="Spike protein S2'" /id="PRO_0000444082"
14-1195 TOPO_DOM /note="Extracellular"
1196-1216 TRANSMEM /note="Helical"
1217-1255 TOPO_DOM /note="Cytoplasmic"
14-290 DOMAIN /note="BetaCoV S1-NTD"
321-513 DOMAIN /note="BetaCoV S1-CTD"
306-527 REGION /note="Receptor-binding domain (RBD)"
424-494 REGION /note="Receptor-binding motif; binding to human ACE2"
798-819 REGION /note="Fusion peptide 1" ECO:0000305|PubMed:29056462"
817-837 REGION /note="Fusion peptide 2" ECO:0000305|PubMed:29056462"
902-952 REGION /note="Heptad repeat 1"
1145-1184 REGION /note="Heptad repeat 2"
931-975 COILED
1157-1185 COILED
1-1255 DISORDER predicted by DISOPRED

MONOMER
1255
pdb_id a1 identity[%]2 description
7sg4 C 99.8 SPIKE_SARS Spike glycoprotein
7akj G 99.6 Q5DIC5_CVHSA Spike glycoprotein
7krq B 77.2 SPIKE_SARS2 Spike glycoprotein 
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue.
HETERO
1255 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
7sg4[1] D DH1047 Heavy chain[232 aa] A 100.0
/99.8		 18
/18		 SPIKE_SARS Spike glycoprotein
7sg4[1] E DH1047 light chain[220 aa] A 100.0
/99.8		 14
/14		 SPIKE_SARS Spike glycoprotein
6nb6[1] E S230 heavy chain[124 aa] B 100.0
/99.7		 1
/1		 SPIKE_CVHSA Spike glycoprotein
6nb6[1] D S230 heavy chain[123 aa] C 100.0
/99.7		 1
/1		 SPIKE_CVHSA Spike glycoprotein
6nb6[5] G S230 light chain[109 aa] B 100.0
/99.7		 3
/3		 SPIKE_CVHSA Spike glycoprotein
7akj[3] C 47D11 neutralizing antibody heavy chain[120 aa] A 100.0
/99.6		 10
/10		 Q5DIC5_CVHSA Spike glycoprotein
7akj[3] D 47D11 neutralizing antibody light chain[106 aa] A 100.0
/99.6		 1
/1		 Q5DIC5_CVHSA Spike glycoprotein
7akj[3] I 47D11 neutralizing antibody light chain[106 aa] A 100.0
/99.6		 3
/3		 Q5DIC5_CVHSA Spike glycoprotein
8gnh[1] D Heavy chain of BD-218[121 aa] B 30.0
/78.2		 10
/10		 SPIKE_SARS2 Spike glycoprotein
8gnh[1] E Light chain of BD-218[106 aa] B 20.0
/78.2		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7ls9[3] B 1-57 Fab heavy chain[129 aa] A 42.9
/77.4		 14
/14		 SPIKE_SARS2 Spike glycoprotein
7dzy[3] I Fab light chain of enhancing antibody 2490[213 aa].. A 33.3
/76.1		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7qti[2] H P2G3 Light Chain[214 aa] I 0.0
/75.7		 1
/1		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
7upw[5] E SP1-77 Fab light chain[212 aa] A 0.0
/77.2		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7upw[6] D SP1-77 Fab heavy chain[225 aa] A 69.2
/77.2		 13
/13		 SPIKE_SARS2 Spike glycoprotein
8gjm[1] D Heavy chain of 17B10 fab[119 aa] A 25.0
/76.9		 8
/8		 SPIKE_SARS2 Spike glycoprotein
8gjm[1] E Light chain of 17B10 fab[106 aa] A 25.0
/76.9		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7swx[1] D SARS2-57 Fv heavy chain[117 aa] A 0.0
/76.9		 4
/9		 SPIKE_SARS2 Spike glycoprotein
7swx[1] E SARS2-57 Fv light chain[112 aa] A 16.7
/76.9		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7mxp[3] F LP5 Fab Heavy Chain[119 aa] A 12.5
/77.0		 8
/15		 SPIKE_SARS2 Spike glycoprotein
7mxp[3] G LP5 Fab Light Chain[107 aa] A 0.0
/77.0		 6
/11		 SPIKE_SARS2 Spike glycoprotein
7wcz[6] B Heavy chain of S5D2 Fab[214 aa] A 33.3
/76.8		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7wcz[6] C Light chain of S5D2 Fab[217 aa] A 20.0
/76.8		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7wd9[5] H Heavy chain of S3H3 Fab[217 aa] A 54.5
/76.8		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7wd9[5] I Light chain of S3H3 Fab[215 aa] A 70.0
/76.8		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7vq0[3] D Neutralizing nanobody P86[116 aa] A 44.4
/77.0		 18
/19		 SPIKE_SARS2 Spike glycoprotein
7vq0[1] D Neutralizing nanobody P86[116 aa] B 60.0
/77.4		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7vq0[1] E Neutralizing nanobody P86[116 aa] C 0.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7l2e[3] D 4-18 heavy chain[122 aa] A 20.0
/76.7		 10
/18		 SPIKE_SARS2 Spike glycoprotein
7l2e[3] E 4-18 light chain[109 aa] A 0.0
/76.7		 4
/8		 SPIKE_SARS2 Spike glycoprotein
7lqv[3] D 4-8 Heavy Chain[125 aa] A 10.0
/76.7		 10
/15		 SPIKE_SARS2 Spike glycoprotein
7lqv[3] E 4-8 Light chain[105 aa] A 0.0
/76.7		 4
/5		 SPIKE_SARS2 Spike glycoprotein
7rw2[3] D 5-7 heavy chain[134 aa] A 59.1
/76.6		 22
/22		 SPIKE_SARS2 Spike glycoprotein
7rw2[3] E 5-7 light chain[106 aa] A 0.0
/76.6		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7l2f[3] D 5-24 heavy chain[126 aa] A 12.5
/76.5		 8
/14		 SPIKE_SARS2 Spike glycoprotein
7x08[3] D heavy chain of 2G1[214 aa] A 28.6
/76.5		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7x08[3] H heavy chain of 2G1[214 aa] A 100.0
/76.5		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7x08[3] E light chain of 2G1[211 aa] A 20.0
/76.5		 5
/5		 SPIKE_SARS2 Spike glycoprotein
8csj[3] B 4-33 heavy chain[122 aa] A 71.4
/76.7		 7
/10		 SPIKE_SARS2 Spike glycoprotein
8csj[3] C 4-33 light chain[110 aa] A 66.7
/76.7		 3
/6		 SPIKE_SARS2 Spike glycoprotein
7fg2[1] B K-874A VHH[116 aa] A 66.7
/76.4		 12
/12		 SPIKE_SARS2 Spike glycoprotein
8cxn[3] D pan-sarbecovirus nanobody 2-57[126 aa] A 93.8
/76.4		 16
/16		 SPIKE_SARS2 Spike glycoprotein
8cxn[1] F pan-sarbecovirus nanobody 2-57[126 aa] C 100.0
/76.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8cxq[3] D pan-sarbecovirus nanobody 1-22[122 aa] A 86.7
/76.4		 15
/15		 SPIKE_SARS2 Spike glycoprotein
8cy6[3] D pan-sarbecovirus nanobody 2-65[122 aa] A 84.6
/76.4		 13
/13		 SPIKE_SARS2 Spike glycoprotein
8cy9[3] D pan-sarbecovirus nanobody 1-23[121 aa] A 88.9
/76.4		 18
/18		 SPIKE_SARS2 Spike glycoprotein
8cya[3] F pan-sarbecovirus nanobody 2-67[127 aa] A 30.0
/76.4		 10
/11		 SPIKE_SARS2 Spike glycoprotein
8cyb[1] D pan-sarbecovirus nanobody 1-8[126 aa] A 95.2
/76.4		 21
/21		 SPIKE_SARS2 Spike glycoprotein
8cyd[3] F pan-sarbecovirus nanobody 2-45[121 aa] A 86.7
/76.4		 15
/15		 SPIKE_SARS2 Spike glycoprotein
7l2d[1] B 1-87 heavy chain[127 aa] A 11.1
/76.4		 9
/16		 SPIKE_SARS2 Spike glycoprotein
7l2d[1] C 1-87 light chain[109 aa] A 33.3
/76.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7tb8[2] F The heavy chain of SARS-CoV-2 antibody A19-61.1[12.. B 33.3
/76.3		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7tb8[1] F The heavy chain of SARS-CoV-2 antibody A19-61.1[12.. C 100.0
/76.3		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7tb8[2] G The light chain of SARS-COV-2 antibody A19-61.1[10.. B 37.5
/76.3		 8
/8		 SPIKE_SARS2 Spike glycoprotein
8cyc[3] D pan-sarbecovirus nanobody 2-34[127 aa] A 93.8
/76.3		 16
/16		 SPIKE_SARS2 Spike glycoprotein
7uz6[2] D M8a-28 Fab heavy chain[119 aa] A 53.8
/76.2		 13
/13		 SPIKE_SARS2 Spike glycoprotein
7uz6[2] E M8a-28 Fab light chain[106 aa] A 71.4
/76.2		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7tpr[3] F Nanobody 7A3[125 aa] A 83.3
/76.1		 18
/18		 SPIKE_SARS2 Spike glycoprotein
7tpr[1] H Nanobody 7A3[125 aa] A 33.3
/76.1		 9
/10		 SPIKE_SARS2 Spike glycoprotein
7tpr[1] F Nanobody 7A3[125 aa] B 75.0
/76.1		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7tpr[1] F Nanobody 7A3[125 aa] C 100.0
/76.1		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7tpr[2] D Nanobody 8A2[132 aa] B 47.8
/76.1		 23
/23		 SPIKE_SARS2 Spike glycoprotein
7dzx[1] D Fab Heavy chain of enhancing antibody[227 aa] C 0.0
/76.1		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7dzy[3] H Fab Heavy chain of enhancing antibody 2490[225 aa].. A 0.0
/76.1		 2
/5		 SPIKE_SARS2 Spike glycoprotein
7we7[3] A Heavy chain of Fab 282[118 aa] C 50.0
/75.9		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7we7[1] A Heavy chain of Fab 282[118 aa] E 100.0
/75.9		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7we7[3] B The light chain of Fab 282[111 aa] C 0.0
/75.9		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7we8[1] D Heavy chain of Fab 265[119 aa] A 41.7
/75.9		 12
/12		 SPIKE_SARS2 Spike glycoprotein
7we8[1] E Light chain of Fab 265[109 aa] A 25.0
/75.9		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7we8[1] E Light chain of Fab 265[109 aa] B 0.0
/75.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7we9[1] D The heavy chain of Fab XGv289[120 aa] A 0.0
/75.9		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7we9[3] E The heavy chain of Fab XGv289[120 aa] A 16.7
/75.9		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7we9[3] G The light chain of Fab XGv289[111 aa] A 50.0
/75.9		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7we9[1] I The light chain of Fab XGv289[111 aa] C 25.0
/75.9		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7wea[7] D The heavy chain of Fab XGv347[123 aa] A 27.3
/75.9		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7wec[2] A The heavy chain of Fab XGv347[123 aa] G 0.0
/75.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wea[7] E The light chain of Fab XGv347[107 aa] A 66.7
/75.9		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7n9t[3] E Nanobody Nb17[119 aa] A 66.7
/75.8		 9
/9		 SPIKE_SARS2 Spike glycoprotein
7n9t[3] F Nanobody Nb17[119 aa] A 0.0
/75.8		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7nd9[1] D COVOX-253H55L Fab heavy chain[219 aa] B 15.4
/78.4		 13
/13		 SPIKE_SARS2 Spike glycoprotein
7qti[1] F P5C3 Heavy Chain[221 aa] K 42.9
/75.7		 7
/8		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
7nd9[1] E COVOX-253H55L Fab light chain[214 aa] B 0.0
/78.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7qti[1] E P5C3 Light Chain[215 aa] K 50.0
/75.7		 6
/6		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
7qti[3] G P2G3 Heavy Chain[228 aa] I 41.7
/75.7		 12
/12		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
7zrv[2] E de novo designed binder[65 aa] B 41.7
/75.6		 12
/13		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
7l2f[3] E 5-24 light chain[109 aa] A 25.0
/76.5		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7ls9[3] C 1-57 Fab light chain[108 aa] A 16.7
/77.4		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7tcc[3] G Light chain of antibody B1-182.1[108 aa] A 100.0
/75.5		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8dzh[1] G antibody MB.02 light chain[109 aa] C 100.0
/75.6		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8dzh[2] D antibody MB.02 heavy chain[118 aa] B 42.9
/75.7		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7wt7[3] D Heavy chain of Fab 9A8[122 aa] C 41.7
/75.6		 12
/12		 SPIKE_SARS2 Spike glycoprotein
7wt7[3] E Light chain of Fab 9A8[107 aa] C 50.0
/75.6		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7wtf[3] A Heavy chain of XGv051[120 aa] C 41.7
/75.6		 12
/12		 SPIKE_SARS2 Spike glycoprotein
7wtf[3] B Light chain of XGv051[104 aa] C 16.7
/75.6		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7wti[3] D Heavy chain of XGv264[118 aa] A 20.0
/75.6		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7wti[3] G Light chain of XGv264[111 aa] A 40.0
/75.6		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7wti[1] G Light chain of XGv264[111 aa] B 50.0
/75.6		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7wtk[3] B Heavy chain of XGv286[118 aa] A 20.0
/75.6		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7wtk[1] F Heavy chain of XGv286[118 aa] A 85.7
/75.6		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7wtk[3] C Light chain of XGv286[109 aa] A 42.9
/75.6		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7wtk[1] H Light chain of XGv286[109 aa] E 40.0
/75.6		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7tca[2] F Heavy chain of antibody A19-46.1[231 aa] B 57.1
/75.5		 7
/7		 SPIKE_SARS2 Spike glycoprotein
7tca[2] G Light chain of antibody A19-46.1[216 aa] B 45.5
/75.5		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7tcc[3] D Heavy chain of antibody A19-46.1[126 aa] A 60.0
/75.5		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7tcc[3] E Light chain of antibody A19-46.1[110 aa] A 46.2
/75.5		 13
/13		 SPIKE_SARS2 Spike glycoprotein
7tcc[3] F heavy chain of antibody B1-182.1[122 aa] A 18.2
/75.5		 11
/11		 SPIKE_SARS2 Spike glycoprotein
6acg[10] D ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] C 100.0
/100.0		 16
/16		 SPIKE_CVHSA Spike glycoprotein
6cs2[1] D ACE2_HUMAN Angiotensin-converting enzyme 2[544 aa] B 100.0
/99.7		 19
/19		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
7yqx[5] F S309 heavy chain[123 aa] A 91.7
/75.2		 12
/12		 SPIKE_SARS2 Spike glycoprotein
7yqy[1] H S309 heavy chain[123 aa] B 50.0
/75.2		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7yqx[5] G S309 light chain[108 aa] A 33.3
/75.2		 3
/3		 SPIKE_SARS2 Spike glycoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
COMPOUND
1255 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
5x58[2502] AA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 4
/4		 Spike glycoprotein
5x58[695] D NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 Spike glycoprotein
5x58[8] F NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 2
/2		 Spike glycoprotein
5x58[3] GA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 Spike glycoprotein
5x58[12] I NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 6
/6		 Spike glycoprotein
5x58[5] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 Spike glycoprotein
5x58[5] Z NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 Spike glycoprotein
6nb6[10] WA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.7		 1
/1		 SPIKE_CVHSA Spike glycoprotein
6nb6[4] XA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.7		 3
/3		 SPIKE_CVHSA Spike glycoprotein
6xlu[186] U NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 50.0
/78.0		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6xlu[36] V NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 50.0
/78.0		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6xlu[2] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/78.2		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xlu[187] LA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 0.0
/78.2		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xm0[12] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 0.0
/78.6		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xm0[57] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/78.6		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6xr8[211] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 0.0
/77.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xr8[84] TA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/77.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zb4[20] F NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/78.1		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zge[6] AB NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 0.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zge[6] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/76.7		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6zgi[2] LA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zoz[3] NA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 0.0
/77.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zoz[50] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 75.0
/77.7		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6zoz[24] Y NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/77.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zp2[3] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/76.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zp2[3] Z NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 75.0
/76.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7akj[6] EA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.6		 1
/1		 Q5DIC5_CVHSA Spike glycoprotein
7akj[3] IA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.6		 1
/1		 Q5DIC5_CVHSA Spike glycoprotein
7akj[3] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.6		 2
/2		 Q5DIC5_CVHSA Spike glycoprotein
7akj[6] KA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.6		 2
/2		 Q5DIC5_CVHSA Spike glycoprotein
7akj[3] TA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.6		 1
/1		 Q5DIC5_CVHSA Spike glycoprotein
7cn4[3] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 0.0
/76.5		 1
/1		 A0A6B9WHD3_CVHSA Spike glycoprotein
7l2f[14] XA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 0.0
/76.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7lqv[2] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 0.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7lqv[3] R NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/76.7		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7lqv[3] S NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/76.7		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7lqv[1] S NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/76.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7sg4[3] F NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 4
/4		 SPIKE_SARS Spike glycoprotein
7sg4[3] IA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS Spike glycoprotein
7sg4[3] M NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS Spike glycoprotein
7sg4[1] YA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/99.8		 5
/5		 SPIKE_SARS Spike glycoprotein
7swx[8] SA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 50.0
/76.9		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7tb4[7] SA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 0.0
/75.4		 1
/1		 A0A8A4XEV3_SARS2 Surface glycoprotein
7tb4[1] AA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 0.0
/75.5		 1
/1		 A0A8A4XEV3_SARS2 Surface glycoprotein
7tb8[6] NA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/76.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7tca[1] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/75.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7to4[4] PA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/76.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7we7[2] NA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		E 100.0
/75.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wg6[2] VA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/76.1		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wgb[1] LA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 83.3
/76.0		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7wgv[6] GA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 0.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wgv[6] HA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 0.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wgv[3] IA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wgv[6] U NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wgv[6] W NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 66.7
/76.7		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7wt8[2] QA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/75.6		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wtf[6] DA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/75.6		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7wtf[2] YA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		C 100.0
/75.6		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wtk[2] FA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		D 0.0
/75.6		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wtk[1] KA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		D 100.0
/75.6		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7xu0[1] AB NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/76.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] MA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 0.0
/76.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybk[3] DB NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 0.0
/77.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7yqx[2] Z NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/75.2		 10
/10		 SPIKE_SARS2 Spike glycoprotein
7zh1[3] K NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.9		 1
/1		 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin
8aja[3] JA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/83.2		 1
/1		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8aja[3] T NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/83.2		 4
/4		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8ajl[3] EA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/88.2		 1
/1		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8ajl[3] X NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/88.2		 1
/1		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8ajl[2] V NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/88.2		 1
/1		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8cya[2] BB NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 0.0
/76.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8gnh[1] P NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		B 100.0
/78.2		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8h0x[16] AA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS Spike glycoprotein
8h0x[19] E NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS Spike glycoprotein
8h0x[15] N NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS Spike glycoprotein
8h0x[23] Q NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 4
/4		 SPIKE_SARS Spike glycoprotein
8h0x[18] R NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS Spike glycoprotein
8h0x[12] UA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS Spike glycoprotein
8h0y[9] W NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS Spike glycoprotein
8h12[6] R NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 3
/3		 SPIKE_SARS Spike glycoprotein
8h12[2] SA NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS Spike glycoprotein
8h12[2] Y NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. 		A 100.0
/99.8		 1
/1		 SPIKE_SARS Spike glycoprotein
6zoz[17] CA BLA
BILIVERDINE IX ALPHA[43 atoms] 		A 75.0
/77.7		 8
/8		 SPIKE_SARS2 Spike glycoprotein
8h0x[11] S BLA
BILIVERDINE IX ALPHA[43 atoms] 		A 100.0
/99.8		 11
/11		 SPIKE_SARS Spike glycoprotein
7wgv[5] EA BLR
3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrr.. 		A 54.5
/76.7		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7qur[3] BA GE9
2,3,5-tris(iodanyl)benzamide[12 atoms] 		A 60.0
/76.6		 5
/5		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7qur[3] CA SIA
N-acetyl-alpha-neuraminic acid[21 atoms] 		A 0.0
/76.6		 6
/8		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7e7b[5] XA VCG
2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-.. 		A 72.7
/76.8		 11
/11		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
7e7b[3] YA VCG
2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-.. 		A 66.7
/76.8		 3
/3		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
7tgx[1] I MAN
alpha-D-mannopyranose[11 atoms] 		A 100.0
/76.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
OTHERPOLY
1255 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
6crw[710] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7		 4
/4		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[79] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7		 1
/1		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[9] J 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7		 2
/2		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[6] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7		 2
/2		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[14] P 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7		 3
/3		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[6] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7		 1
/1		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[6] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.7		 2
/2		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crx[2] BA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7		 1
/1		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crx[4] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7		 5
/5		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crx[67] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7		 1
/1		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crx[151] W 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.7		 2
/2		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crz[212] P 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.7		 4
/4		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6cs1[2] T 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7		 2
/2		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6nb6[1] U 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7		 1
/1		 SPIKE_CVHSA Spike glycoprotein
6nb7[11] KA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.7		 1
/1		 SPIKE_CVHSA Spike glycoprotein
6nb7[100] W 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6nb7[1] KA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/99.7		 1
/1		 SPIKE_CVHSA Spike glycoprotein
6xlu[38] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/78.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xlu[155] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 40.0
/78.0		 5
/5		 SPIKE_SARS2 Spike glycoprotein
6xm3[6] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 50.0
/78.5		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6xr8[57] E 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 0.0
/77.3		 1
/3		 SPIKE_SARS2 Spike glycoprotein
6xr8[32] U 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/77.3		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6zge[6] E 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 0.0
/76.7		 1
/3		 SPIKE_SARS2 Spike glycoprotein
6zge[9] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 80.0
/76.7		 5
/5		 SPIKE_SARS2 Spike glycoprotein
6zge[10] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 66.7
/76.7		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6zge[6] J 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 75.0
/76.7		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6zge[53] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.7		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6zge[3] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zge[9] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.7		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6zge[9] R 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 33.3
/76.7		 6
/6		 SPIKE_SARS2 Spike glycoprotein
6zgf[10] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 33.3
/78.5		 3
/3		 A0A6B9WHD3_CVHSA Spike glycoprotein
6zgf[3] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/78.5		 1
/1		 A0A6B9WHD3_CVHSA Spike glycoprotein
6zgf[23] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/78.5		 3
/3		 A0A6B9WHD3_CVHSA Spike glycoprotein
6zoz[24] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/77.7		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7akj[3] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.6		 4
/4		 Q5DIC5_CVHSA Spike glycoprotein
7akj[3] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.6		 1
/1		 Q5DIC5_CVHSA Spike glycoprotein
7akj[3] O 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.6		 4
/4		 Q5DIC5_CVHSA Spike glycoprotein
7akj[15] X 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.6		 1
/1		 Q5DIC5_CVHSA Spike glycoprotein
7akj[3] Y 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.6		 1
/1		 Q5DIC5_CVHSA Spike glycoprotein
7cn8[3] W 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.8		 1
/1		 Glycoprotein
7cn8[1] BA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/76.8		 1
/1		 Glycoprotein
7e7b[69] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 75.0
/76.8		 4
/4		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
7jjj[2] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/76.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7krr[6] R 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 0.0
/76.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7n1q[36] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/77.1		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7n1v[2] AA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7n1v[10] Z 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 0.0
/76.6		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7sbl[1] Y 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 0.0
/77.1		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7swx[4] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.9		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7swx[1] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 0.0
/76.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7swx[1] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/76.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7tb4[10] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/75.4		 1
/1		 A0A8A4XEV3_SARS2 Surface glycoprotein
7vq0[1] AA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/77.0		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7vrv[1] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.1		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7vrv[1] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.1		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7vrv[1] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 0.0
/76.1		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7we7[2] T 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/75.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wg6[3] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 66.7
/76.1		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7wg6[1] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/76.1		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wg7[1] G 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/75.9		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wgv[3] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wtf[1] U 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 100.0
/75.6		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybh[3] E 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/76.5		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybh[2] L 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 66.7
/76.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7ybh[4] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/76.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybh[4] R 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B 100.0
/76.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7ybh[2] Q 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. C 0.0
/76.2		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8aja[3] E 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/83.2		 4
/4		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8aja[3] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 75.0
/83.2		 4
/4		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8ajl[3] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 75.0
/88.2		 4
/4		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8h0z[7] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 100.0
/99.8		 4
/4		 SPIKE_SARS Spike glycoprotein
7akj[3] N alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. A 100.0
/99.6		 3
/3		 Q5DIC5_CVHSA Spike glycoprotein
6zgf[3] M alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. A 100.0
/78.5		 1
/1		 A0A6B9WHD3_CVHSA Spike glycoprotein
6zgf[3] W alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. A 33.3
/78.5		 3
/3		 A0A6B9WHD3_CVHSA Spike glycoprotein
6crw[3] U alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. C 100.0
/99.7		 3
/3		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6cs2[1] U alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. B 100.0
/99.7		 3
/3		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6nb6[2] DA alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. B 100.0
/99.7		 5
/5		 SPIKE_CVHSA Spike glycoprotein
6nb7[1] GA alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. B 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
7tf8[1] K alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. B 100.0
/78.2		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6xr8[3] O alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. A 100.0
/77.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xr8[12] D alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 75.0
/77.3		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6xr8[41] G alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 57.1
/77.3		 7
/7		 SPIKE_SARS2 Spike glycoprotein
6xr8[31] J alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 66.7
/77.3		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6xr8[3] JA alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 0.0
/77.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xr8[38] K alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6xr8[3] L alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.3		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6xr8[38] M alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.3		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6xr8[90] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 75.0
/77.3		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6xr8[31] V alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 50.0
/77.3		 6
/6		 SPIKE_SARS2 Spike glycoprotein
7krq[47] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.2		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7krq[5] S alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 0.0
/77.2		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7n1q[36] K alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.1		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7n1t[20] J alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 75.0
/76.9		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7sbk[6] H alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 75.0
/77.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7sbk[9] M alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7sbk[5] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 50.0
/77.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7sbk[10] X alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7sbp[13] N alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 50.0
/77.6		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7sbp[9] O alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.6		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7sbp[8] Z alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.6		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7sbt[3] K alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 0.0
/76.3		 2
/7		 SPIKE_SARS2 Spike glycoprotein
7to4[7] O alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 0.0
/76.3		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybk[3] J alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 75.0
/77.0		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7ybk[3] K alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/77.0		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6xr8[93] F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 75.0
/77.3		 4
/4		 SPIKE_SARS2 Spike glycoprotein
6zgf[3] H 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 50.0
/78.5		 2
/2		 A0A6B9WHD3_CVHSA Spike glycoprotein
7akj[3] K 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/99.6		 5
/5		 Q5DIC5_CVHSA Spike glycoprotein
7jjj[2] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/76.6		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. C 66.7
/76.5		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7nd9[1] P 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. B 0.0
/78.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7upw[6] T 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/77.2		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7ybk[3] I 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/77.0		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cya[2] X 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. A 100.0
/76.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7qur[6] G alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. A 50.0
/76.6		 2
/2		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7qur[6] K alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. A 66.7
/76.6		 3
/3		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8csj[1] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(2-3)-2-a.. D 0.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8csj[1] M 2-acetamido-2-deoxy-beta-D-glucopyranose-(2-3)-2-a.. E 66.7
/76.5		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7tgx[1] D alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/76.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7tgx[1] E alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. A 100.0
/76.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7tgx[1] F alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. B 50.0
/76.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7tgx[1] G alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. B 100.0
/76.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
6crw[9] D beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7		 1
/1		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[5] L beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7		 3
/3		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[9] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7		 5
/5		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[11] W beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7		 5
/5		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crx[7] F beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7		 1
/1		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crz[3] R beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7		 1
/1		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crz[5] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7		 4
/4		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crz[3] R beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7		 2
/2		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6cs2[36] V beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7		 1
/1		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6nb6[6] H beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6nb6[4] I beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6nb6[1] IA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6nb6[5] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7		 1
/1		 SPIKE_CVHSA Spike glycoprotein
6nb6[6] K beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7		 3
/3		 SPIKE_CVHSA Spike glycoprotein
6nb6[6] L beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6nb6[40] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6nb6[5] Y beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/99.7		 3
/3		 SPIKE_CVHSA Spike glycoprotein
6nb6[8] CA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7		 4
/4		 SPIKE_CVHSA Spike glycoprotein
6nb6[2] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7		 1
/1		 SPIKE_CVHSA Spike glycoprotein
6nb6[5] W beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6nb6[1] HA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6nb6[5] IA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6nb6[2] SA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6zgf[3] I beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 66.7
/78.5		 3
/3		 A0A6B9WHD3_CVHSA Spike glycoprotein
7l2d[6] K beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 66.7
/76.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7l2d[5] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 40.0
/76.4		 5
/5		 SPIKE_SARS2 Spike glycoprotein
7ls9[4] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 33.3
/77.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7qo7[1] F beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 33.3
/75.9		 3
/3		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7qo7[4] G beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/75.9		 1
/1		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7qo7[9] L beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/75.9		 2
/2		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7qo7[2] P beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/75.9		 1
/1		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7qo7[2] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 0.0
/75.8		 1
/1		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7wg6[9] I beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 75.0
/76.1		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7wg6[2] J beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/76.1		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7wtf[5] M beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/75.6		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] F beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 50.0
/76.5		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7ybh[3] H beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/76.5		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7ybh[2] V beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 75.0
/76.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] CA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/76.2		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] P beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 25.0
/76.2		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7zrv[1] G beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 75.0
/75.7		 4
/4		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
7zrv[1] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 50.0
/75.7		 2
/2		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
8cya[5] G beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 100.0
/76.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8cya[1] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 0.0
/76.4		 1
/1		 SPIKE_SARS2 Spike glycoprotein
8cya[1] S beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/76.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8cya[2] T beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 66.7
/76.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6crw[7] E alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/99.7		 3
/3		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[3] F alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/99.7		 3
/3		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[7] T alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/99.7		 1
/1		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[6] O alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. B 100.0
/99.7		 4
/4		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6crw[1] R alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. C 100.0
/99.7		 5
/5		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6cs2[1] P alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. B 100.0
/99.7		 2
/2		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6nb7[2] T alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 100.0
/99.7		 4
/4		 SPIKE_CVHSA Spike glycoprotein
7qo7[1] D alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 60.0
/75.9		 5
/5		 A0A8A4XEV3_SARS2 A0A2Z5WJZ7_9CAUD Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron..
7qti[1] X alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. K 66.7
/75.7		 3
/3		 SPIKE_SARS2 M1E1E4_9HIV1 Spike glycoprotein,Envelope glycoprotein
7tf8[2] H alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 75.0
/78.2		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7tf8[2] O alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. B 100.0
/78.2		 2
/2		 SPIKE_SARS2 Spike glycoprotein
7ybh[1] J alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. A 66.7
/76.5		 3
/3		 SPIKE_SARS2 Spike glycoprotein
6cs1[1] G alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7		 4
/4		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6cs1[1] H alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7		 4
/4		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6cs1[1] S alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. B 100.0
/99.7		 1
/1		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6cs1[1] S alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. C 100.0
/99.7		 2
/2		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6nb6[2] M alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
6nb6[6] O alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7		 5
/5		 SPIKE_CVHSA Spike glycoprotein
6nb6[2] P alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7		 4
/4		 SPIKE_CVHSA Spike glycoprotein
6nb6[2] Q alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7		 4
/4		 SPIKE_CVHSA Spike glycoprotein
6nb6[3] R alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/99.7		 2
/2		 SPIKE_CVHSA Spike glycoprotein
7tf8[1] I alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/78.2		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7tf8[1] L alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 25.0
/78.2		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7tf8[1] L alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. B 50.0
/78.2		 4
/4		 SPIKE_SARS2 Spike glycoprotein
7tf8[2] N alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. B 75.0
/78.2		 4
/4		 SPIKE_SARS2 Spike glycoprotein
8cyb[1] F alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/76.4		 2
/2		 SPIKE_SARS2 Spike glycoprotein
8cyb[2] G alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 66.7
/76.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cyb[2] H alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 100.0
/76.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cyb[2] J alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. A 75.0
/76.4		 4
/4		 SPIKE_SARS2 Spike glycoprotein
8cyb[1] I alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-.. A 100.0
/76.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cyb[1] N beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B 66.7
/76.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
8cyb[1] X alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. C 66.7
/76.4		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] HC beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 100.0
/76.5		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] TA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. C 66.7
/76.5		 3
/3		 SPIKE_SARS2 Spike glycoprotein
7yqx[5] K beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 50.0
/75.2		 4
/4		 SPIKE_SARS2 Spike glycoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
HOMO
1255 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
5x58[53] B Spike glycoprotein[1053 aa] A 100.0
/99.8		 110
/110		 Spike glycoprotein
5x58[50] C Spike glycoprotein[1052 aa] A 100.0
/99.8		 93
/93		 Spike glycoprotein
5xlr[21] B SPIKE_CVHSA Spike glycoprotein[1022 aa] A 100.0
/100.0		 69
/69		 SPIKE_CVHSA Spike glycoprotein
5xlr[21] C SPIKE_CVHSA Spike glycoprotein[1022 aa] A 100.0
/100.0		 77
/77		 SPIKE_CVHSA Spike glycoprotein
6nb6[6] B SPIKE_CVHSA Spike glycoprotein[1026 aa] A 100.0
/99.7		 61
/61		 SPIKE_CVHSA Spike glycoprotein
6nb6[6] C SPIKE_CVHSA Spike glycoprotein[1055 aa] A 100.0
/99.7		 71
/71		 SPIKE_CVHSA Spike glycoprotein
7akj[3] B Q5DIC5_CVHSA Spike glycoprotein[1084 aa] A 100.0
/99.6		 60
/60		 Q5DIC5_CVHSA Spike glycoprotein
7zh1[3] B SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin[1020 aa] A 100.0
/99.9		 95
/95		 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin
7zh1[3] C SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin[1020 aa] A 100.0
/99.9		 104
/104		 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin
7zh5[1] C SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin[962 aa] A 100.0
/100.0		 76
/76		 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin
7zh5[1] A SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin[904 aa] C 100.0
/100.0		 74
/74		 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin
8h16[1] B SPIKE_SARS Spike glycoprotein[805 aa] A 100.0
/100.0		 60
/60		 SPIKE_SARS Spike glycoprotein
8h16[1] B SPIKE_SARS Spike glycoprotein[805 aa] C 100.0
/100.0		 77
/77		 SPIKE_SARS Spike glycoprotein
8h13[3] B SPIKE_SARS Spike glycoprotein[931 aa] A 98.6
/99.8		 72
/72		 SPIKE_SARS Spike glycoprotein
8h13[3] C SPIKE_SARS Spike glycoprotein[931 aa] A 98.4
/99.8		 62
/62		 SPIKE_SARS Spike glycoprotein
6cs2[1] A SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin[891 aa] B 100.0
/99.7		 64
/64		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
6cs2[1] C SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin[893 aa] B 98.6
/99.7		 72
/72		 SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin
8ajl[3] B SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[1109 aa] A 95.1
/88.2		 102
/102		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8ajl[3] C SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[1109 aa] A 98.2
/88.2		 113
/113		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8aja[3] B SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[1090 aa] A 90.1
/83.2		 121
/121		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
8aja[3] C SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[1090 aa] A 93.3
/83.2		 104
/104		 SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin
7tpl[1] A SPIKE_SARS2 Spike glycoprotein[423 aa] B 93.3
/79.0		 45
/45		 SPIKE_SARS2 Spike glycoprotein
6xlu[383] B SPIKE_SARS2 Spike glycoprotein[1061 aa] A 85.8
/78.0		 106
/106		 SPIKE_SARS2 Spike glycoprotein
6xlu[92] C SPIKE_SARS2 Spike glycoprotein[1060 aa] A 86.7
/78.0		 98
/98		 SPIKE_SARS2 Spike glycoprotein
6xr8[290] C SPIKE_SARS2 Spike glycoprotein[1107 aa] A 87.8
/77.3		 123
/123		 SPIKE_SARS2 Spike glycoprotein
6zge[9] B SPIKE_SARS2 Spike glycoprotein[1098 aa] A 87.0
/76.7		 108
/108		 SPIKE_SARS2 Spike glycoprotein
6zge[9] C SPIKE_SARS2 Spike glycoprotein[1098 aa] A 88.3
/76.7		 94
/94		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] F SPIKE_SARS2 Spike glycoprotein[1108 aa] A 77.8
/76.6		 9
/9		 SPIKE_SARS2 Spike glycoprotein
7jjj[2] D SPIKE_SARS2 Spike glycoprotein[1120 aa] C 14.3
/76.5		 7
/12		 SPIKE_SARS2 Spike glycoprotein
7lqv[3] B SPIKE_SARS2 Spike glycoprotein[1112 aa] A 84.9
/76.7		 86
/86		 SPIKE_SARS2 Spike glycoprotein
7lqv[3] C SPIKE_SARS2 Spike glycoprotein[1087 aa] A 90.2
/76.7		 82
/82		 SPIKE_SARS2 Spike glycoprotein
7n9t[3] B SPIKE_SARS2 Spike glycoprotein[1123 aa] A 85.5
/75.8		 69
/69		 SPIKE_SARS2 Spike glycoprotein
7n9t[5] C SPIKE_SARS2 Spike glycoprotein[1123 aa] A 86.5
/75.8		 74
/74		 SPIKE_SARS2 Spike glycoprotein
7vhl[2] B SPIKE_SARS2 Spike glycoprotein[1083 aa] A 90.0
/76.1		 80
/80		 SPIKE_SARS2 Spike glycoprotein
7cn8[3] B Glycoprotein[1125 aa] A 85.6
/76.8		 111
/111		 Glycoprotein
7cn8[3] C Glycoprotein[1125 aa] A 86.9
/76.8		 107
/107		 Glycoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
PRECIPITANT
1255 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
6zb4[16] V EIC
LINOLEIC ACID[20 atoms] 		B 100.0
/78.1		 6
/6		 SPIKE_SARS2 Spike glycoprotein
6zb4[35] V EIC
LINOLEIC ACID[20 atoms] 		C 100.0
/78.2		 1
/1		 SPIKE_SARS2 Spike glycoprotein
6zp2[18] DA EIC
LINOLEIC ACID[20 atoms] 		A 92.3
/76.4		 13
/13		 SPIKE_SARS2 Spike glycoprotein
7cn8[2] TA EIC
LINOLEIC ACID[20 atoms] 		A 92.3
/76.8		 13
/13		 Glycoprotein
7wgv[3] AA EIC
LINOLEIC ACID[20 atoms] 		A 93.3
/76.7		 15
/15		 SPIKE_SARS2 Spike glycoprotein
7wgv[6] AB EIC
LINOLEIC ACID[20 atoms] 		A 100.0
/76.7		 1
/1		 SPIKE_SARS2 Spike glycoprotein
7zh1[3] G EIC
LINOLEIC ACID[20 atoms] 		A 100.0
/99.9		 8
/8		 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin
7zh2[3] G EIC
LINOLEIC ACID[20 atoms] 		A 100.0
/99.9		 11
/11		 SPIKE_SARS WAC_BPT4 Spike glycoprotein,Fibritin
8h0x[15] D EIC
LINOLEIC ACID[20 atoms] 		A 100.0
/99.8		 11
/11		 SPIKE_SARS Spike glycoprotein
8h0x[14] T EIC
LINOLEIC ACID[20 atoms] 		A 100.0
/99.8		 3
/3		 SPIKE_SARS Spike glycoprotein
7e7b[6] VA ELA
9-OCTADECENOIC ACID[20 atoms] 		A 100.0
/76.8		 14
/14		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
7e7b[6] WA ELA
9-OCTADECENOIC ACID[20 atoms] 		A 100.0
/76.8		 4
/4		 SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain
7z3z[2] EA STE
STEARIC ACID[20 atoms] 		A 90.9
/77.2		 11
/11		 SPIKE_SARS2 Spike glycoprotein
7z3z[2] RA STE
STEARIC ACID[20 atoms] 		A 100.0
/77.2		 2
/2		 SPIKE_SARS2 Spike glycoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.